Peng, B., & Gong, J. (2017). Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC). Urol Case Rep.
Παραπομπή Chicago StylePeng, Bo, και Jin Gong. "Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)." Urol Case Rep 2017.
Παραπομπή MLAPeng, Bo, και Jin Gong. "Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)." Urol Case Rep 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.